Bio-Thera Solutions, Ltd.

SHSE:688177 Stock Report

Market Cap: CN¥8.3b

Bio-Thera Solutions Management

Management criteria checks 1/4

Bio-Thera Solutions' CEO is Shengfeng Li, appointed in Mar 2019, has a tenure of 5.75 years. directly owns 12.97% of the company’s shares, worth CN¥1.08B. The average tenure of the management team and the board of directors is 1.8 years and 5.8 years respectively.

Key information

Shengfeng Li

Chief executive officer

CN¥2.4m

Total compensation

CEO salary percentagen/a
CEO tenure5.8yrs
CEO ownership13.0%
Management average tenure1.8yrs
Board average tenure5.8yrs

Recent management updates

Recent updates

We Think Bio-Thera Solutions (SHSE:688177) Has A Fair Chunk Of Debt

Dec 17
We Think Bio-Thera Solutions (SHSE:688177) Has A Fair Chunk Of Debt

Optimistic Investors Push Bio-Thera Solutions, Ltd. (SHSE:688177) Shares Up 44% But Growth Is Lacking

Oct 09
Optimistic Investors Push Bio-Thera Solutions, Ltd. (SHSE:688177) Shares Up 44% But Growth Is Lacking

Time To Worry? Analysts Just Downgraded Their Bio-Thera Solutions, Ltd. (SHSE:688177) Outlook

Sep 05
Time To Worry? Analysts Just Downgraded Their Bio-Thera Solutions, Ltd. (SHSE:688177) Outlook

Bio-Thera Solutions, Ltd. (SHSE:688177) Shares May Have Slumped 30% But Getting In Cheap Is Still Unlikely

Jun 06
Bio-Thera Solutions, Ltd. (SHSE:688177) Shares May Have Slumped 30% But Getting In Cheap Is Still Unlikely

Some Confidence Is Lacking In Bio-Thera Solutions, Ltd. (SHSE:688177) As Shares Slide 27%

Apr 18
Some Confidence Is Lacking In Bio-Thera Solutions, Ltd. (SHSE:688177) As Shares Slide 27%

Subdued Growth No Barrier To Bio-Thera Solutions, Ltd. (SHSE:688177) With Shares Advancing 30%

Mar 04
Subdued Growth No Barrier To Bio-Thera Solutions, Ltd. (SHSE:688177) With Shares Advancing 30%

CEO

Shengfeng Li (65 yo)

5.8yrs

Tenure

CN¥2,408,100

Compensation

Mr. Shengfeng Li is Founder, CEO, GM & Chairman of Bio-Thera Solutions, Ltd. from May 20, 2022. He was Founder, CEO, GM & Director of Bio-Thera Solutions, Ltd.until May 20, 2022. He was Founder, CEO & Dir...


Leadership Team

NamePositionTenureCompensationOwnership
Shengfeng Li
Founder5.8yrsCN¥2.41m12.97%
CN¥ 1.1b
Jinchen Yu
Presidentless than a yearCN¥2.52mno data
Cui Hua Liu
Deputy GMno dataCN¥2.18mno data
Xianming Huang
SVP of Discovery Research & Directorno dataCN¥2.18mno data
Dan Yu
Executive Director & Secretary to the Board2.6yrsCN¥847.90k0.069%
CN¥ 5.8m
Bryan Yu
Senior Vice President of Technology Developmentno datano datano data
Cai Bao
Senior Vice President of Qualityless than a yearno datano data

1.8yrs

Average Tenure

59yo

Average Age

Experienced Management: 688177's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Shengfeng Li
Founder5.8yrsCN¥2.41m12.97%
CN¥ 1.1b
Jinchen Yu
President5.8yrsCN¥2.52mno data
Cui Hua Liu
Deputy GM2.6yrsCN¥2.18mno data
Xianming Huang
SVP of Discovery Research & Director5.6yrsCN¥2.18mno data
Dan Yu
Executive Director & Secretary to the Board5.8yrsCN¥847.90k0.069%
CN¥ 5.8m
Jun Qiu
Director5.8yrsno datano data
Wang Jianping
Independent Director5.8yrsno datano data
Xiao Yun Wu
Chairman of the Board of Supervisors5.8yrsno datano data
Dehan Huang
Independent Director2.6yrsCN¥120.00k0.046%
CN¥ 3.8m
Henry Wei
Independent Director2.6yrsCN¥120.00kno data

5.8yrs

Average Tenure

59yo

Average Age

Experienced Board: 688177's board of directors are considered experienced (5.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 20:46
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bio-Thera Solutions, Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yanyin ZhuChina International Capital Corporation Limited
Shitong HanCitic Securities Co., Ltd.
Yinglan ShuHaitong International Research Limited